|
|
Volumn 55, Issue 24, 1998, Pages 2593-
|
|
Etanercept marketed for moderate, severe rheumatoid arthritis.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN G;
LIGAND;
NONSTEROID ANTIINFLAMMATORY AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ARTICLE;
CLINICAL TRIAL;
DRUG RESISTANCE;
HUMAN;
RHEUMATOID ARTHRITIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
DRUG RESISTANCE;
HUMANS;
IMMUNOGLOBULIN G;
LIGANDS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
|
EID: 0032534276
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/55.24.2593 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|